Samsung Biologics announces expanded strategic agreement with Bristol Myers Squibb to manufacture an antibody cancer drug substance

Bristol Myers Squibb and Samsung Biologics have an existing manufacturing agreement for a commercial antibody cancer drug and have expanded the strategic r...

September 21, 2023 | Thursday | News
BostonGene and Hokkaido University Hospital Collaborate to Develop Novel HER2 Protocols for Breast Cancer

Located in Sapporo, Japan, Hokkaido University Hospital stands as one of the most prominent medical institutions in the country. Affiliated with Hokkaido U...

September 20, 2023 | Wednesday | News
AHF Slams Johnson & Johnson for Immoral Profiteering on TB Treatment

“While shocking, this move by Johnson & Johnson is unfortunately not surprising – we demand that the company halt its profiteering tactics ...

September 20, 2023 | Wednesday | News
Kineta Announces New Research Agreement to Evaluate VISTA Biomarker Expression

The primary objective is to evaluate VISTA as a biomarker to guide patient selection and treatment optimization for VISTA-targeted therapies where no stand...

September 19, 2023 | Tuesday | News
Mayo Clinic and GE HealthCare Enter Strategic Collaboration to Advance Innovation in Medical Imaging and Theranostics

Mayo Clinic and GE HealthCare announce a strategic healthcare collaboration for research and product development programs aimed to transform the experience...

September 15, 2023 | Friday | News
GeneType Breakthrough for Pancreatic Cancer, Melanoma, and Atrial Fibrillation Approved in Australia

Genetic Technologies Limited (GTG), a pioneering global leader in genomics-based tests focused on health, wellness, and the battle against serious diseases...

September 13, 2023 | Wednesday | News
SomaLogic Identifies Key Proteins for Early Cancer Detection

SomaLogic’s SomaScan® platform was used to target 15 markers shared among all cancer types. In a new paper published in Nature's Scientific Repo...

September 13, 2023 | Wednesday | News
Clover Launches Quadrivalent Seasonal Influenza Vaccine in Mainland China

Second commercialized product strengthens Clover’s leading respiratory vaccine franchise and financial profile--   Clover Biopharmaceutica...

September 12, 2023 | Tuesday | News
Revolutionizing Hyperbaric Oxygen Therapy: BARIKS Unveils Game-Changing Portable Chambers

In an exclusive interview with Yoav Blat, BARIKS' Representative in North America, we explore the technology behind this chamber and its potential to revol...

September 11, 2023 | Monday | News
Bristol Myers Squibb's LPA1 Antagonist Slows Lung Decline in Pulmonary Fibrosis Study

Results show 26 weeks of treatment with twice-daily 60 mg dose of BMS-986278 resulted in a 69% relative reduction in the rate of decline in percent predict...

September 11, 2023 | Monday | News
HumanFirst Launches Enterprise Platform for Clinical Research Advancements

HumanFirst, a cloud-based software company accelerating patient-centered drug development through AI-powered insights, today announced the launch of the in...

September 11, 2023 | Monday | News
Clearmind Medicine Collaborates with Johns Hopkins to Study CMND-100 for Alcohol Use Disorder

The principal investigator, Jennifer Ellis, PhD, Associate Professor of Psychiatry and Behavioral Sciences, JHU School of Medicine will be supported by co-...

September 07, 2023 | Thursday | News
Revvity Launches Next-Gen Imaging Tools to Drive Research Breakthroughs

IVIS® Spectrum 2 and IVIS SpectrumCT 2imaging systems — new flagship platforms setting the standard in high-throughput performance and versat...

September 06, 2023 | Wednesday | News
Stallergenes Greer & Nestlé Partner for Palforzia® Peanut Allergy Treatment

Peanut allergy currently affects approximately 2% of the general population of Western nations1, and the prevalence of peanut allergy doubled among childre...

September 05, 2023 | Tuesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in